[HTML][HTML] Safety monitoring of COVID-19 vaccine booster doses among adults—United States, September 22, 2021–February 6, 2022

AM Hause - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
AM Hause
MMWR. Morbidity and mortality weekly report, 2022cdc.gov
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States,
September 22, 2021–February 6, 2022 | MMWR Skip directly to site content Skip directly to
page options Skip directly to AZ link Centers for Disease Control and Prevention. CDC twenty
four seven. Saving Lives, Protecting People Search Submit Morbidity and Mortality Weekly
Report (MMWR) Section Navigation CDC Home Facebook Twitter LinkedIn Syndicate Safety
Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September …
Review of surveillance data found that local and systemic reactions were less frequent after a homologous COVID-19 mRNA vaccine booster dose than after the second primary vaccine dose. Myocarditis was rarely reported following an mRNA vaccine booster dose.
cdc.gov